Grants

PI Name PI Organization Title Grant Number Initiative Program Director
Lenburg, Marc Elliott

Boston University Medical Campus
United States

Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules 5R01CA210360-06 Richard Mazurchuk, Ph.D.
Cheng, Leo L

Massachusetts General Hospital
United States

Novel metabolomic contrast probes for human lung cancer characterization 1R01CA273010-01 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Guillermo Marquez, Ph.D.
Zhang, Hui

Johns Hopkins University
United States

Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer 3U01CA152813-10S1 Richard Mazurchuk, Ph.D.
Singal, Amit

Ut Southwestern Medical Center
United States

Clinical Validation Center for Hepatocellular Carcinoma 1U01CA271887-01 RFA-CA-21-033 (U01 Clinical Trial Optional) Sharmistha Ghosh-Janjigian, Ph.D.
Singal, Amit

Ut Southwestern Medical Center
United States

Clinical Validation Center for Hepatocellular Carcinoma 1U01CA271887-01 RFA-CA-21-033 (U01 Clinical Trial Optional) Sharmistha Ghosh-Janjigian, Ph.D.
Nappi, Lucia

Provincial Health Services Authority
United States

Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration. 1R37CA264798-01 PAR-19-264 (R01 Clinical Trial Optional) Guillermo Marquez, Ph.D.
Nappi, Lucia

Provincial Health Services Authority
United States

Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration. 1R37CA264798-01 PAR-19-264 (R01 Clinical Trial Optional) Guillermo Marquez, Ph.D.
Mallick, Parag Kumar

Stanford University
United States

Pathomic Predictors of Prostate Cancer Progression 5R01CA249899-03 PAR-19-264 (R01 Clinical Trial Optional) Richard Mazurchuk, Ph.D.
Mallick, Parag Kumar

Stanford University
United States

Pathomic Predictors of Prostate Cancer Progression 5R01CA249899-03 PAR-19-264 (R01 Clinical Trial Optional) Richard Mazurchuk, Ph.D.
Kuhs, Krystle A.

University Of Kentucky
United States

Circulating HPV DNA as a Prediagnostic Marker of Oropharyngeal Cancer 1R21CA267152-01A1 Wendy Wang, Ph.D., M.Sc.